Estimating the fitness cost and benefit of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy: A modelling study. (2017)
Attributed to:
MRC Centre for Outbreak Analysis and Modelling Renewal
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1371/journal.pmed.1002416
PubMed Identifier: 29088226
Publication URI: http://europepmc.org/abstract/MED/29088226
Type: Journal Article/Review
Volume: 14
Parent Publication: PLoS medicine
Issue: 10
ISSN: 1549-1277